Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/CANTARGIA-AB-31837413/attualita/Cantargia-segnala-il-primo-paziente-con-NSCLC-non-squamoso-trattato-con-Nadunolimab-Keytruda-e-ch-41833301/?utm_source=whatsapp&utm_medium=social&utm_campaign=share